Search Page

1

Cite

Share

Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma.

Armand P, Janssens A, Gritti G, Radford J, Timmerman J, Pinto A, Mercadal Vilchez S, Johnson P, Cunningham D, Leonard JP, Rodig SJ, Martín-Regueira P, Sumbul A, Samakoglu S, Tang H, Ansell SM. Armand P, et al. Among authors: samakoglu s. Blood. 2021 Feb 4;137(5):637-645. doi: 10.1182/blood.2019004753. Blood. 2021. PMID: 32870269 Free PMC article. Clinical Trial.

Cite

Share

2

Cite

Share

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.

Ansell SM, Minnema MC, Johnson P, Timmerman JM, Armand P, Shipp MA, Rodig SJ, Ligon AH, Roemer MGM, Reddy N, Cohen JB, Assouline S, Poon M, Sharma M, Kato K, Samakoglu S, Sumbul A, Grigg A. Ansell SM, et al. Among authors: samakoglu s. J Clin Oncol. 2019 Feb 20;37(6):481-489. doi: 10.1200/JCO.18.00766. Epub 2019 Jan 8. J Clin Oncol. 2019. PMID: 30620669 Free PMC article. Clinical Trial.

Cite

Share

3

Cite

Share

Progress toward the genetic treatment of the beta-thalassemias.

Sadelain M, Lisowski L, Samakoglu S, Rivella S, May C, Riviere I. Sadelain M, et al. Among authors: samakoglu s. Ann N Y Acad Sci. 2005;1054:78-91. doi: 10.1196/annals.1345.010. Ann N Y Acad Sci. 2005. PMID: 16339654 Review.

Cite

Share

4

Cite

Share

Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.

Sadelain M, Rivella S, Lisowski L, Samakoglu S, Rivière I. Sadelain M, et al. Among authors: samakoglu s. Best Pract Res Clin Haematol. 2004 Sep;17(3):517-34. doi: 10.1016/j.beha.2004.08.002. Best Pract Res Clin Haematol. 2004. PMID: 15498721 Review.

Cite

Share

5

Cite

Share

A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.

Hong D, Rasco D, Veeder M, Luke JJ, Chandler J, Balmanoukian A, George TJ, Munster P, Berlin JD, Gutierrez M, Mita A, Wakelee H, Samakoglu S, Guan S, Dimery I, Graef T, Borazanci E. Hong D, et al. Among authors: samakoglu s. Oncology. 2019;97(2):102-111. doi: 10.1159/000500571. Epub 2019 Jun 21. Oncology. 2019. PMID: 31230047 Free article. Clinical Trial.

Cite

Share

6

Cite

Share

Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC.

Samakoglu S, Deevi DS, Li H, Wang S, Murphy M, Bao C, Bassi R, Prewett M, Tonra JR. Samakoglu S, et al. Cancer Genomics Proteomics. 2012 Mar-Apr;9(2):77-92. Cancer Genomics Proteomics. 2012. PMID: 22399498

Cite

Share

7

Cite

Share

Estimating preclinical efficacy targets utilizing cetuximab efficacy in KRAS mutant and wild-type colorectal cancer models.

Prewett M, Bassi R, Paz K, Amatulli M, Deevi D, Li H, Wang S, Witte L, Samakoglu S, Tonra JR. Prewett M, et al. Among authors: samakoglu s. Anticancer Res. 2011 Jun;31(6):2149-60. Anticancer Res. 2011. PMID: 21737635

Cite

Share

8

Cite

Share

A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.

Samakoglu S, Lisowski L, Budak-Alpdogan T, Usachenko Y, Acuto S, Di Marzo R, Maggio A, Zhu P, Tisdale JF, Rivière I, Sadelain M. Samakoglu S, et al. Nat Biotechnol. 2006 Jan;24(1):89-94. doi: 10.1038/nbt1176. Epub 2005 Dec 25. Nat Biotechnol. 2006. PMID: 16378095

Cite

Share

9

Cite

Share

Quantitative analysis of clinically relevant mutations occurring in lymphoid cells harboring gamma-retrovirus-encoded hsvtk suicide genes.

Wang X, Olszewska M, Capacio V, Stefanski J, Przybylowski M, Samakoglu S, Chang AH, Sadelain M, Rivière I. Wang X, et al. Among authors: samakoglu s. Gene Ther. 2008 Nov;15(21):1454-9. doi: 10.1038/gt.2008.103. Epub 2008 Jun 19. Gene Ther. 2008. PMID: 18563185 Free PMC article.

Cite

Share

10

Cite

Share

Pleiotropic stromal effects of vascular endothelial growth factor receptor 2 antibody therapy in renal cell carcinoma models.

Duignan IJ, Corcoran E, Pennello A, Plym MJ, Amatulli M, Claros N, Iacolina M, Youssoufian H, Witte L, Samakoglu S, Schwartz J, Surguladze D, Tonra JR. Duignan IJ, et al. Among authors: samakoglu s. Neoplasia. 2011 Jan;13(1):49-59. doi: 10.1593/neo.101162. Neoplasia. 2011. PMID: 21245940 Free PMC article.

Cite

Share